SPIA
IRD

Steward Partners Investment Advisory’s Opus Genetics IRD Stock Holding History

Steward Partners Investment Advisory’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$87 – 7449
2021
Q1 		$87 Buy
+15
New +$139 ﹤0.01% 3392

Other funds holding IRD

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
NPF
Norris Perne & French Grand Rapids, Michigan $1.71B AUM 30.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's IRD Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Opus Genetics (IRD) in Q2 2021, closing a stake of 15 shares — an estimated $87 sold.

Steward Partners Investment Advisory first reported a position in IRD in Q1 2021 and held it in 1 quarter. The position peaked at $87 in Q1 2021. 36 funds tracked by Wall St. Rank hold IRD as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Opus Genetics position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 15 Opus Genetics shares in Q2 2021, an estimated $87.
  • Steward Partners Investment Advisory first reported a position in Opus Genetics in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Opus Genetics position peaked at $87 in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.